UBS O'Connor’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

UBS O'Connor’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-122,070	Closed	-$12.2M	–	1047
2015 Q1	$12.2M	Buy	+122,070	New	+$8.13M	0.12%	205

UBS O'Connor's ASPX Position: Q2 2015 in Review

UBS O'Connor sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 122,070 shares — an estimated $12.2M sold.

UBS O'Connor first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $12.2M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

UBS O'Connor reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
UBS O'Connor sold 122,070 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $12.2M.
UBS O'Connor first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
UBS O'Connor's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $12.2M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on UBS O'Connor's 13F filing for Q2 2015, filed 13 Aug 2015.